Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics

盘后交易 07-17 17:19:34 EDT

1.26

-0.04

-3.08%

盘后1.26

+0.000.00%

16:00 EDT

最高1.34	最低1.26	成交量25.94万
今开1.28	昨收1.30	日振幅5.93%
总市值5,234万	流通市值2,836万	总股本4,154万
成交额33.36万	换手率1.15%	流通股本2,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":1.26,"timestamp":1721246400000,"preClose":1.3,"halted":0,"volume":259357,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:00 EDT","volume":27,"amount":34.02,"timestamp":1721246403127},"delay":0,"floatShares":22510463,"shares":41542744,"eps":-2.002197,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.04,"latestTime":"07-17 17:19:34 EDT","open":1.28,"high":1.3371,"low":1.26,"amount":333637.363514,"amplitude":0.059308,"askPrice":1.32,"askSize":100,"bidPrice":1.27,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-2.002197,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.3,"latestTime":"09:29 EDT","volume":8624,"amount":11181.886161600001,"timestamp":1721222971029},"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:00 EDT","volume":27,"amount":34.02,"timestamp":1721246403127},"volumeRatio":0.604817},"requestUrl":"/m/hq/s/CARM/tweets","defaultTab":"tweets","newsList":[{"id":"2452432917","title":"Carisma Therapeutics, Inc.盘中异动 大幅上涨5.55%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452432917","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452432917?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:31","pubTimestamp":1721147488,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时31分，Carisma Therapeutics, Inc.股票出现异动，股价急速上涨5.55%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003128941f77d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003128941f77d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2451621751","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451621751","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451621751?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:05","pubTimestamp":1721055916,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时05分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715230516941f7142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715230516941f7142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2450361742","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450361742","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450361742?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:31","pubTimestamp":1720708270,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时31分，Carisma Therapeutics, Inc.股票出现异动，股价快速拉升5.19%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223110af91e017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223110af91e017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2450028495","title":"Carisma Therapeutics, Inc.盘中异动 大幅下跌5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450028495","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450028495?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:44","pubTimestamp":1720532648,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时44分，Carisma Therapeutics, Inc.股票出现异动，股价快速跳水5.04%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709214408af915984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709214408af915984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2449703358","title":"Carisma Therapeutics, Inc.盘中异动 快速上涨7.83%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449703358","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449703358?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445515,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Carisma Therapeutics, Inc.股票出现异动，股价快速上涨7.83%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131559590a86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131559590a86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2449926035","title":"Carisma Therapeutics, Inc.盘中异动 大幅跳水6.83%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449926035","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449926035?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:31","pubTimestamp":1720186278,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时31分，Carisma Therapeutics, Inc.股票出现异动，股价急速跳水6.83%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213118aef82cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213118aef82cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2448855154","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448855154","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448855154?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:03","pubTimestamp":1720015420,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时03分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌6.21%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070322034096819367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070322034096819367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2448913495","title":"Carisma Therapeutics, Inc.盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913495","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913495?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:38","pubTimestamp":1719841098,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时38分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213818af900823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213818af900823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2446102683","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨26.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446102683","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446102683?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581514,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Carisma Therapeutics, Inc.股票出现异动，股价急速上涨26.95%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131549f713936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131549f713936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2446155623","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446155623","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446155623?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:14","pubTimestamp":1719497686,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时14分，Carisma Therapeutics, Inc.股票出现波动，股价快速下挫5.33%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221446aef6f1c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221446aef6f1c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2446139498","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446139498","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446139498?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:26","pubTimestamp":1719411989,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时26分，Carisma Therapeutics, Inc.股票出现异动，股价快速拉升5.22%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222629968171a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222629968171a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2446453849","title":"Carisma Therapeutics, Inc.盘中异动 大幅跳水6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446453849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446453849?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:37","pubTimestamp":1719322638,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时37分，Carisma Therapeutics, Inc.股票出现波动，股价大幅下挫6.25%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521371896816a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521371896816a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2446899688","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446899688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446899688?lang=zh_cn&edition=full","pubTime":"2024-06-25 03:54","pubTimestamp":1719258871,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日03时54分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升6.37%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062503543196816507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062503543196816507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2444198132","title":"Carisma Therapeutics, Inc.盘中异动 早盘快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444198132","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444198132?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:08","pubTimestamp":1718633326,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时08分，Carisma Therapeutics, Inc.股票出现波动，股价大幅下挫5.26%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617220846941eefae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617220846941eefae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2443328591","title":"Carisma Therapeutics, Inc.盘中异动 临近收盘快速下挫5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443328591","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443328591?lang=zh_cn&edition=full","pubTime":"2024-06-13 03:42","pubTimestamp":1718221355,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日03时42分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下跌5.65%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613034235af8d36cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613034235af8d36cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2442223548","title":"Carisma Therapeutics, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442223548","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442223548?lang=zh_cn&edition=full","pubTime":"2024-06-11 01:29","pubTimestamp":1718040590,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日01时29分，Carisma Therapeutics, Inc.股票出现波动，股价快速上涨5.56%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611012951aef42d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611012951aef42d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2441463724","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441463724","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441463724?lang=zh_cn&edition=full","pubTime":"2024-06-07 03:46","pubTimestamp":1717703217,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日03时46分，Carisma Therapeutics, Inc.股票出现异动，股价快速下挫5.22%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607034658941ed076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607034658941ed076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2440236483","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速下挫5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440236483","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440236483?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:01","pubTimestamp":1717509672,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时01分，Carisma Therapeutics, Inc.股票出现异动，股价急速下跌5.38%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220112af8bef3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220112af8bef3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2439578302","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439578302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439578302?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:02","pubTimestamp":1716991343,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时02分，Carisma Therapeutics, Inc.股票出现异动，股价急速下跌5.22%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529220224af8aee98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529220224af8aee98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2438370391","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438370391","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438370391?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:39","pubTimestamp":1716903562,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时39分，Carisma Therapeutics, Inc.股票出现异动，股价急速下跌5.19%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213923941ea9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213923941ea9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":0.1504},{"period":"1month","weight":0.1404},{"period":"3month","weight":-0.2308},{"period":"6month","weight":-0.4468},{"period":"1year","weight":-0.857},{"period":"ytd","weight":-0.5563}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CARISMA Therapeutics Inc.是临床阶段生物制药公司，拥有一个专有的蛋白质工程平台，称为 AMP-Rx，它用于发现和发展蛋白质疗法来治疗眼疾。其治疗方法基于在有疾病的眼睛中的细胞因子，以及它对细胞因子的结构认知和理性设计操控蛋白质调节细胞因子影响的能力。细胞因子是细胞信号分子，在可以产生重要的炎症部分上发现。该公司认为细胞因子在许多眼部疾病的基本病理机制中发挥重要作用，蛋白质疗法是调节眼睛的疾病中细胞因子的影响的有效手段。该公司已利用其 AMP Rx 平台理性设计、操控和生成创新性蛋白治疗候选药物渠道把细胞因子作为靶子，并认为这是控制眼疾的关键。该公司现正进行针对前面的眼睛疾病，包括干眼症疾病和过敏性结膜炎等疾病和后面的眼睛，糖尿病黄斑水肿或二甲醚和葡萄膜炎等疾病的研究和发展方案。 Eleven生物药物公司2008年2月25日在特拉华州法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.118068},{"month":2,"riseRate":0.3,"avgChangeRate":0.03966},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.09024},{"month":4,"riseRate":0.545455,"avgChangeRate":0.307249},{"month":5,"riseRate":0.545455,"avgChangeRate":0.110205},{"month":6,"riseRate":0.727273,"avgChangeRate":0.139785},{"month":7,"riseRate":0.181818,"avgChangeRate":0.050324},{"month":8,"riseRate":0.5,"avgChangeRate":-0.021472},{"month":9,"riseRate":0.4,"avgChangeRate":-0.081868},{"month":10,"riseRate":0.4,"avgChangeRate":-0.069827},{"month":11,"riseRate":0.5,"avgChangeRate":0.024269},{"month":12,"riseRate":0.5,"avgChangeRate":-0.004255}],"exchange":"NASDAQ","name":"Carisma Therapeutics","nameEN":"Carisma Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics,CARM,Carisma Therapeutics股票,Carisma Therapeutics股票老虎,Carisma Therapeutics股票老虎国际,Carisma Therapeutics行情,Carisma Therapeutics股票行情,Carisma Therapeutics股价,Carisma Therapeutics股市,Carisma Therapeutics股票价格,Carisma Therapeutics股票交易,Carisma Therapeutics股票购买,Carisma Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}